About us
Amarna’s next-generation viral vector platform promises to transform treatment across many disease areas."

Management Team

Ben van Leent – Chief Executive Officer & Co-founder
Ben has more than 25 years’ experience in the information, communication and technology market. At the end of 1988, after several Sales and Management positions at Esso and Unisys, he became an entrepreneur. As managing director of Benton Software International B.V, he was responsible for the sales and implementation of data communication software (XCOM6.2) in e.g. the financial world. Later he represented Entrust Inc., in the Benelux, a market leader in the field of encryption. He was responsible for the sales and implementation of PKI-infrastructures configured to send data encrypted in the form of a so-called "Digital Signature". Users were Interpay, S.W.I.F.T. and the Dutch Inland Revenue Service (electronic declaration of tax). He has extensive expertise in entrepreneurial activities and is highly experienced in major business issues such as IP, technology, legal, finance as well as business strategy.

Peter de Haan PhD – Chief Scientific Officer and Co-founder
Peter is a biologist, with more than 20 years in management research in plant biotechnology. He also co-founded Phytovation BV, which is developing a therapeutic AIDS vaccine. Peter has strong expertise in molecular cloning, tissue culture of mammalian cells and production of recombinant virus particles in mammalian cell systems. He has (co-) authored more than 50 peer reviewed scientific articles and (co-) invented more than 12 different patents and patent applications. He obtained his PhD in virology from the Wageningen University in the Netherlands in 1991.